SRPT
Sarepta Therapeutics Inc
17.50$
+1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +100.0% | -50.0% | +1,197.3% | -45.6% | +18.5% | +15.9% | -55.6% | +1,011.3% | -97.6% | +9,428.2% | +93.5% | -17.3% | +67.3% | +59.7% | -20.6% | -61.9% | -31.4% | -87.2% | +332.6% | +2,751.6% | +94.7% | +26.5% | +41.8% | +30.0% | +32.9% | +33.3% | +53.0% | +15.6% | |
| – | – | – | – | – | – | +59.8% | -26.1% | +28.5% | -13.9% | +52.7% | +35.7% | -14.6% | -11.8% | -13.4% | +30.8% | +44.6% | +73.8% | +4.2% | +55.4% | -99.9% | +5,556.2% | +365.0% | +65.5% | +12.0% | +53.1% | +44.2% | +7.4% | +112.2% | +176.2% | |
| – | +0.0% | -33.3% | -75.0% | +1,613.8% | -58.8% | +18.5% | +15.9% | -55.6% | +1,011.3% | -97.6% | +9,428.2% | +93.5% | -17.3% | -88.8% | +463.9% | -232.0% | – | – | – | +322.3% | +2,682.7% | +81.2% | +21.5% | +47.0% | +26.9% | +31.1% | +37.8% | +44.8% | -16.8% | |
| – | +58.8% | +133.3% | +6.3% | +38.3% | +37.6% | +75.8% | -31.8% | +35.7% | -17.5% | +48.1% | +37.1% | -16.6% | -15.9% | +47.5% | +85.9% | -21.6% | +39.1% | +29.2% | +55.4% | +28.6% | -11.5% | +141.0% | +39.6% | +28.8% | +6.8% | +13.7% | +0.0% | -8.3% | +89.2% | |
| – | +116.7% | +23.1% | +6.3% | +33.5% | +47.9% | +12.1% | +21.1% | +3.9% | +9.4% | +49.6% | +20.4% | +5.0% | -11.2% | +65.4% | +11.6% | -8.9% | +116.0% | +56.1% | +52.2% | +8.2% | +47.6% | +75.2% | +35.6% | +11.6% | -11.1% | +59.7% | +6.7% | +15.8% | -14.1% | |
| – | +60.7% | +80.0% | +3.7% | +42.3% | +34.7% | +62.5% | -24.2% | +28.4% | -12.5% | +48.4% | +33.2% | -12.0% | -14.7% | +52.2% | +64.7% | -19.2% | +55.9% | +37.4% | +54.3% | +22.8% | +6.8% | +110.2% | +68.7% | +1.1% | +2.3% | +24.9% | +2.4% | +0.3% | +44.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -401.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +32.0% | -24.2% | -73.8% | -100.0% | – | -100.0% | – | -60.8% | +980.6% | +483.1% | -9.0% | +95.5% | +6.0% | -16.2% | -58.7% | -16.4% | -47.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -369.3% | |
| – | -400.0% | – | – | – | – | -65.1% | -205.9% | – | – | – | – | – | +50.5% | +16.5% | -410.5% | – | -77.7% | -108.3% | – | – | – | -133.6% | – | -11.0% | -115.8% | – | +17.4% | +60.8% | -56.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -403.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -304.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.